Acne

Latest News


CME Content


Gluten and gluten-sensitive enteropathy have become hot topics among the lay public and in medical practices. John Zone, M.D., from the University of Utah, Salt Lake City, discusses how gluten sensitive enteropathy may impact many areas of dermatology.

I thoroughly enjoyed the lead article about “antimicrobial stewardship” in the October edition of Dermatology Times (“Antimicrobial stewardship: How dermatologists can be part of the solution, Vol. 34, No. 10). It succinctly and effectively detailed that for healthcare providers in general and dermatologists in specific, it is our duty to utilize antimicrobials appropriately.

New drugs, data and guidelines on acne and rosacea treatment were among the takeaways from days two and three of MauiDerm 2014. Presenters also described evidence-based suggestions for managing pigmentary disorders and updated information on infectious diseases.

Most patients that complain of acne within 48 hours of applying sunscreen probably are not experiencing true acne with follicular rupture, but rather irritant follicular contact dermatitis or possibly miliaria rubra and miliaria pustulosa. It may be worthwhile to suggest patients try a spray formulation.

Although the symptoms of acne and rosacea are well established, clear and definitive etiologies of these conditions have largely been unknown. Recent research, however, has shed new light into the pathophysiology of these conditions, paving the way for more targeted therapies.

Dermatologists generally know that the sensitivity of many pathogens to the antibiotics used to treat them is decreasing, experts say. But many dermatologists may not appreciate their specialty’s role in potentially fueling the problem.

Even though bacteria such as Propionibacterium acnes share the same genus and species, says an expert, recent research suggests that different P. acnes strains may behave differently, which could have profound implications for acne treatment.

The Food and Drug Administration has approved the topical acne drug Epiduo (adapalene 01. percent/benzoyl peroxide 2.5 percent, Galderma) in children ages 9 and older, according to a news release.